Aurinia Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$17.36

-0.17 (-0.97%)

As of Jun 23, 1:50 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 69%

Hold 4 31%

Sell 0 0%

Price Target

Analyst Price Target +134.1% upside

Low Target $34.07

Average Target $40.64

High Target $61.77

Current Price $17.36

Current
$17.36

Target
$40.64

$34.07 $40.64 avg $61.77

Scenario Analysis

Bear Case

$34.07

96.3%

Low target

Base Case

$40.64

+134.1%

Avg target

Bull Case

$61.77

+255.8%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$16.88

2.8% from high

52-Week Low

$7.29

+138.3% from low

Target vs 52W High

$40.64

+140.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%